Previous close | 1.1000 |
Open | 1.1100 |
Bid | 1.1600 x 43500 |
Ask | 1.1600 x 47300 |
Day's range | 1.1000 - 1.2000 |
52-week range | 1.0300 - 2.5450 |
Volume | |
Avg. volume | 22,652,055 |
Market cap | 2.497B |
Beta (5Y monthly) | 1.42 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency (DARPA) to achieve DARPA's objectives under its new Ice Control for cold Environments (ICE) program.
AQUA Cultured Foods, a food tech company producing alternative seafood options through the use of microbial fermentation, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership. AQUA has chosen Ginkgo to help optimize its innovative fermentation technology to elevate the quality of its fish-free seafood products that authentically replicate the look, feel, and taste of fresh-caught seafood. Leveraging Ginkgo
Imagindairy, an Israeli-based foodtech company developing sustainable and commercially viable animal-free dairy proteins, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership. Together, Ginkgo and Imagindairy aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner. This collaboration will leverage Ginkgo Protein Expression Services and Imagindair